4//SEC Filing
Glenn Jeffrey S 4
Accession 0001209191-17-051449
CIK 0001305253other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 6:20 PM ET
Size
6.4 KB
Accession
0001209191-17-051449
Insider Transaction Report
Form 4
Glenn Jeffrey S
Director
Transactions
- Purchase
Common Stock
2017-09-01$9.53/sh+15,000$142,950→ 31,355 total
Holdings
- 460(indirect: By son)
Common Stock
- 151,064(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001670382
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 6:20 PM ET
- Size
- 6.4 KB